401 Episodes

  1. Episode 203: Renee Saliby in the Rising Star series

    Published: 11/14/2022
  2. Episode 202: The Uromigos Paper of the Month - Docetaxel with or without continuous enza in CRPC

    Published: 11/7/2022
  3. Episode 201: PARPi in CRPC

    Published: 11/1/2022
  4. Episode 200: Chromophobe renal cancer

    Published: 10/25/2022
  5. Episode 199: The Uromigos Paper of the Month - FGFR inhibition in bladder cancer

    Published: 10/17/2022
  6. Episode 198: The RADICALS trial in prostate cancer

    Published: 10/7/2022
  7. Episode 197: The Uromigos Nashville 2022

    Published: 9/29/2022
  8. Episode 196: The COSMIC-313 Trial cabo/ipi/nivo in 1st line renal cancer

    Published: 9/14/2022
  9. Episode 195 ESMO 2022: EV Pembrolizumab in 1st line bladder cancer

    Published: 9/13/2022
  10. Episode 194 ESMO 2022: Pegylated il-2 + nivolumab in renal cancer

    Published: 9/12/2022
  11. Episode 193 ESMO 2022: PRESTO - a phase III trial of androgen annihilation in biochemically relapsed prostate cancer

    Published: 9/11/2022
  12. Episode 192 ESMO 2022: Summary of ESMO Adjuvant RCC Trials

    Published: 9/11/2022
  13. Episode 191 ESMO 2022: PROSPER study of neoadjuvant nivolumab in RCC

    Published: 9/10/2022
  14. Episode 190: ESMO 2022 Preview

    Published: 9/2/2022
  15. Episode 189: The Uromigos Paper of the Month - Robotic vs open cystectomy

    Published: 8/22/2022
  16. Episode 188: The 1st Uromigos Live and Unplugged face-to-face meeting

    Published: 8/15/2022
  17. Episode 187: Cora Sternberg - The Uromigos Legends Series

    Published: 8/15/2022
  18. Episode 186: Bernard Escudier - The Uromigos Legends Series

    Published: 8/10/2022
  19. Episode 185: The Uromigos Paper of the Month - ctDNA in prostate cancer

    Published: 8/1/2022
  20. Episode 184: Active surveillance in prostate cancer and the seeds of doubt

    Published: 7/26/2022

11 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London